Notch Initiates the Endothelial-to-Mesenchymal Transition in the Atrioventricular Canal through Autocrine Activation of Soluble Guanylyl Cyclase

Developmental Cell

Volumn 21, Issue 2, 2011, Pages 288-300

  Chang, Alex C Y ^a   Fu, YangXin ^a   Garside, Victoria C ^b   Niessen, Kyle ^a   Chang, Linda ^a   Fuller, Megan ^a,c   Setiadi, Audi ^a   Smrz, Justin ^a   Kyle, Alastair ^a   Minchinton, Andrew ^a,c   Marra, Marco ^a,c   Hoodless, Pamela A ^b,c   Karsan, Aly ^a,c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; GAMMA SECRETASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INHIBIN; JAGGED1; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NOTCH RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATRIOVENTRICULAR CANAL; AUTOCRINE EFFECT; BINDING SITE; CELL MIGRATION; CONTROLLED STUDY; ENDOCARDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; EX VIVO STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; IN SITU HYBRIDIZATION; IN VIVO STUDY; MOUSE; NONHUMAN; PARACRINE SIGNALING; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF;

ANIMALS; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; ENDOCARDIAL CUSHIONS; ENDOTHELIUM; FEMALE; GENE EXPRESSION PROFILING; GUANYLATE CYCLASE; MALE; MESODERM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, NOTCH; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 79961240429     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2011.06.022     Document Type: Article

References (58)

1. Aicher D., Urbich C., Zeiher A., Dimmeler S., Schäfers H.J. Endothelial nitric oxide synthase in bicuspid aortic valve disease. Ann. Thorac. Surg. 2007, 83:1290-1294.
2. Arrington C.B., Yost H.J. Extra-embryonic syndecan 2 regulates organ primordia migration and fibrillogenesis throughout the zebrafish embryo. Development 2009, 136:3143-3152.
3. Baker D.A., Kelly J.M. Structure, function and evolution of microbial adenylyl and guanylyl cyclases. Mol. Microbiol. 2004, 52:1229-1242.
4. Camenisch T.D., Molin D.G., Person A., Runyan R.B., Gittenberger-de Groot A.C., McDonald J.A., Klewer S.E. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev. Biol. 2002, 248:170-181.
5. Cheng C., van Haperen R., de Waard M., van Damme L.C., Tempel D., Hanemaaijer L., van Cappellen G.W., Bos J., Slager C.J., Duncker D.J., et al. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. Blood 2005, 106:3691-3698.
6. DeHaan R.L. Development of pacemaker tissue in the embryonic heart. Ann. N Y Acad. Sci. 1965, 127:7-18.
7. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003, 4:3.
8. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605.
9. Donovan J., Kordylewska A., Jan Y.N., Utset M.F. Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Curr. Biol. 2002, 12:1605-1610.
10. Eisenberg L.M., Markwald R.R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 1995, 77:1-6.
11. Eldadah Z.A., Hamosh A., Biery N.J., Montgomery R.A., Duke M., Elkins R., Dietz H.C. Familial Tetralogy of Fallot caused by mutation in the jagged1 gene. Hum. Mol. Genet. 2001, 10:163-169.
12. Feng Q., Song W., Lu X., Hamilton J.A., Lei M., Peng T., Yee S.P. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 2002, 106:873-879.
13. Feng Q., Di R., Tao F., Chang Z., Lu S., Fan W., Shan C., Li X., Yang Z. PDK1 regulates vascular remodeling and promotes epithelial-mesenchymal transition in cardiac development. Mol. Cell. Biol. 2010, 30:3711-3721.
14. Fischer A., Schumacher N., Maier M., Sendtner M., Gessler M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 2004, 18:901-911.
15. Fischer A., Steidl C., Wagner T.U., Lang E., Jakob P.M., Friedl P., Knobeloch K.P., Gessler M. Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ. Res. 2007, 100:856-863.
16. Friebe A., Mergia E., Dangel O., Lange A., Koesling D. Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase. Proc. Natl. Acad. Sci. USA 2007, 104:7699-7704.
17. Fu Y., Chang A., Chang L., Niessen K., Eapen S., Setiadi A., Karsan A. Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells. J. Biol. Chem. 2009, 284:19452-19462.
18. Fukumura D., Kashiwagi S., Jain R.K. The role of nitric oxide in tumour progression. Nat. Rev. Cancer 2006, 6:521-534.
19. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399:597-601.
20. Garg V., Muth A.N., Ransom J.F., Schluterman M.K., Barnes R., King I.N., Grossfeld P.D., Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature 2005, 437:270-274.
21. Giuili G., Scholl U., Bulle F., Guellaën G. Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain. FEBS Lett. 1992, 304:83-88.
22. Groneberg D., König P., Wirth A., Offermanns S., Koesling D., Friebe A. Smooth muscle-specific deletion of nitric oxide-sensitive guanylyl cyclase is sufficient to induce hypertension in mice. Circulation 2010, 121:401-409.
23. Hamaguchi Y., Yamamoto Y., Iwanari H., Maruyama S., Furukawa T., Matsunami N., Honjo T. Biochemical and immunological characterization of the DNA binding protein (RBP-J kappa) to mouse J kappa recombination signal sequence. J. Biochem. 1992, 112:314-320.
24. Harrington L.S., Sainson R.C., Williams C.K., Taylor J.M., Shi W., Li J.L., Harris A.L. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvasc. Res. 2008, 75:144-154.
25. High F.A., Epstein J.A. The multifaceted role of Notch in cardiac development and disease. Nat. Rev. Genet. 2008, 9:49-61.
26. High F.A., Lu M.M., Pear W.S., Loomes K.M., Kaestner K.H., Epstein J.A. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc. Natl. Acad. Sci. USA 2008, 105:1955-1959.
27. Hove J.R., Köster R.W., Forouhar A.S., Acevedo-Bolton G., Fraser S.E., Gharib M. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 2003, 421:172-177.
28. Ignarro L.J., Harbison R.G., Wood K.S., Kadowitz P.J. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J. Pharmacol. Exp. Ther. 1986, 237:893-900.
29. Iso T., Kedes L., Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J. Cell. Physiol. 2003, 194:237-255.
30. Lee T.C., Zhao Y.D., Courtman D.W., Stewart D.J. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 2000, 101:2345-2348.
31. Li L., Krantz I.D., Deng Y., Genin A., Banta A.B., Collins C.C., Qi M., Trask B.J., Kuo W.L., Cochran J., et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 1997, 16:243-251.
32. Luna-Zurita L., Prados B., Grego-Bessa J., Luxán G., del Monte G., Benguría A., Adams R.H., Pérez-Pomares J.M., de la Pompa J.L. Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. J. Clin. Invest. 2010, 120:3493-3507.
33. Masumura T., Yamamoto K., Shimizu N., Obi S., Ando J. Shear stress increases expression of the arterial endothelial marker ephrinB2 in murine ES cells via the VEGF-Notch signaling pathways. Arterioscler. Thromb. Vasc. Biol. 2009, 29:2125-2131.
34. Meadows K.N., Iyer S., Stevens M.V., Wang D., Shechter S., Perruzzi C., Camenisch T.D., Benjamin L.E. Akt promotes endocardial-mesenchyme transition. J. Angiogenes. Res. 2009, 1:2.
35. Mergia E., Russwurm M., Zoidl G., Koesling D. Major occurrence of the new alpha2beta1 isoform of NO-sensitive guanylyl cyclase in brain. Cell. Signal. 2003, 15:189-195.
36. Mergia E., Friebe A., Dangel O., Russwurm M., Koesling D. Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. J. Clin. Invest. 2006, 116:1731-1737.
37. Michell B.J., Griffiths J.E., Mitchelhill K.I., Rodriguez-Crespo I., Tiganis T., Bozinovski S., de Montellano P.R., Kemp B.E., Pearson R.B. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 1999, 9:845-848.
38. Mount P.F., Kemp B.E., Power D.A. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J. Mol. Cell. Cardiol. 2007, 42:271-279.
39. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 1986, 78:1-5.
40. Nakajima Y., Yamagishi T., Hokari S., Nakamura H. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat. Rec. 2000, 258:119-127.
41. Niessen K., Karsan A. Notch signaling in cardiac development. Circ. Res. 2008, 102:1169-1181.
42. Niessen K., Fu Y., Chang L., Hoodless P.A., McFadden D., Karsan A. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J. Cell Biol. 2008, 182:315-325.
43. Nonaka S., Shiratori H., Saijoh Y., Hamada H. Determination of left-right patterning of the mouse embryo by artificial nodal flow. Nature 2002, 418:96-99.
44. Noseda M., McLean G., Niessen K., Chang L., Pollet I., Montpetit R., Shahidi R., Dorovini-Zis K., Li L., Beckstead B., et al. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ. Res. 2004, 94:910-917.
45. Oda T., Elkahloun A.G., Pike B.L., Okajima K., Krantz I.D., Genin A., Piccoli D.A., Meltzer P.S., Spinner N.B., Collins F.S., Chandrasekharappa S.C. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat. Genet. 1997, 16:235-242.
46. Pyriochou A., Beis D., Koika V., Potytarchou C., Papadimitriou E., Zhou Z., Papapetropoulos A. Soluble guanylyl cyclase activation promotes angiogenesis. J. Pharmacol. Exp. Ther. 2006, 319:663-671.
47. Pyriochou A., Vassilakopoulos T., Zhou Z., Papapetropoulos A. cGMP-dependent and -independent angiogenesis-related properties of nitric oxide. Life Sci. 2007, 81:1549-1554.
48. Pyriochou A., Zhou Z., Koika V., Petrou C., Cordopatis P., Sessa W.C., Papapetropoulos A. The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway. J. Cell. Physiol. 2007, 211:197-204.
49. Rastaldo R., Pagliaro P., Cappello S., Penna C., Mancardi D., Westerhof N., Losano G. Nitric oxide and cardiac function. Life Sci. 2007, 81:779-793.
50. Sessa W.C. Molecular control of blood flow and angiogenesis: role of nitric oxide. J. Thromb. Haemost. 2009, 7(Suppl 1):35-37.
51. Siddiqui A.S., Khattra J., Delaney A.D., Zhao Y., Astell C., Asano J., Babakaiff R., Barber S., Beland J., Bohacec S., et al. A mouse atlas of gene expression: large-scale digital gene-expression profiles from precisely defined developing C57BL/6J mouse tissues and cells. Proc. Natl. Acad. Sci. USA 2005, 102:18485-18490.
52. Sun D., Mcalmon K.R., Davies J.A., Bernfield M., Hay E.D. Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation. Int. J. Dev. Biol. 1998, 42:733-736.
53. Timmerman L.A., Grego-Bessa J., Raya A., Bertrán E., Pérez-Pomares J.M., Díez J., Aranda S., Palomo S., McCormick F., Izpisúa-Belmonte J.C., de la Pompa J.L. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004, 18:99-115.
54. Vrljicak P., Chang A.C., Morozova O., Wederell E.D., Niessen K., Marra M.A., Karsan A., Hoodless P.A. Genomic analysis distinguishes phases of early development of the mouse atrio-ventricular canal. Physiol. Genomics 2010, 40:150-157.
55. Vyas-Read S., Shaul P.W., Yuhanna I.S., Willis B.C. Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293:L212-L221.
56. Wang X.L., Fu A., Raghavakaimal S., Lee H.C. Proteomic analysis of vascular endothelial cells in response to laminar shear stress. Proteomics 2007, 7:588-596.
57. Yamagami S., Suzuki N. Diverse forms of guanylyl cyclases in medaka fish - their genomic structure and phylogenetic relationships to those in vertebrates and invertebrates. Zoolog. Sci. 2005, 22:819-835.
58. Ziegler T., Silacci P., Harrison V.J., Hayoz D. Nitric oxide synthase expression in endothelial cells exposed to mechanical forces. Hypertension 1998, 32:351-355.